Dr. Martens PLC (DOCS) - Net Assets
Based on the latest financial reports, Dr. Martens PLC (DOCS) has net assets worth GBX329.10 Million GBX (≈ $40.04K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX865.40 Million ≈ $105.29K USD) and total liabilities (GBX536.30 Million ≈ $65.25K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Dr. Martens PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX329.10 Million |
| % of Total Assets | 38.03% |
| Annual Growth Rate | 64.75% |
| 5-Year Change | 143.13% |
| 10-Year Change | N/A |
| Growth Volatility | 530.82 |
Dr. Martens PLC - Net Assets Trend (2014–2025)
This chart illustrates how Dr. Martens PLC's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Dr. Martens PLC for the complete picture of this company's asset base.
Annual Net Assets for Dr. Martens PLC (2014–2025)
The table below shows the annual net assets of Dr. Martens PLC from 2014 to 2025. For live valuation and market cap data, see DOCS stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | GBX366.40 Million ≈ $44.58K |
-0.49% |
| 2024-03-31 | GBX368.20 Million ≈ $44.80K |
-8.91% |
| 2023-03-31 | GBX404.20 Million ≈ $49.18K |
+23.16% |
| 2022-03-31 | GBX328.20 Million ≈ $39.93K |
+117.78% |
| 2021-03-31 | GBX150.70 Million ≈ $18.34K |
+113.76% |
| 2020-03-31 | GBX70.50 Million ≈ $8.58K |
+939.29% |
| 2019-03-31 | GBX-8.40 Million ≈ $-1.02K |
+71.43% |
| 2018-03-31 | GBX-29.40 Million ≈ $-3.58K |
-63.33% |
| 2017-03-31 | GBX-18.00 Million ≈ $-2.19K |
-63.64% |
| 2016-03-31 | GBX-11.00 Million ≈ $-1.34K |
-1475.00% |
| 2015-03-31 | GBX800.00K ≈ $97.34 |
-46.98% |
| 2014-03-31 | GBX1.51 Million ≈ $183.60 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dr. Martens PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 175685000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX1.75 Billion | 477.37% |
| Common Stock | GBX9.60 Million | 2.62% |
| Total Equity | GBX366.40 Million | 100.00% |
Dr. Martens PLC Competitors by Market Cap
The table below lists competitors of Dr. Martens PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sintex Plastics Technology Limited
NSE:SPTL
|
$7.29 Million |
|
Morgan Advanced Materials plc
LSE:MGAM
|
$7.29 Million |
|
Raj Oil Mills Limited
NSE:ROML
|
$7.32 Million |
|
Digitree Group S.A
WAR:DTR
|
$7.32 Million |
|
Anmol India Limited
NSE:ANMOL
|
$7.29 Million |
|
FUTURE METALS NL
F:3R10
|
$7.28 Million |
|
Dhruv Consultancy Services Limited
NSE:DHRUV
|
$7.28 Million |
|
Koba Resources Ltd
AU:KOB
|
$7.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr. Martens PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 368,200,000 to 366,400,000, a change of -1,800,000 (-0.5%).
- Net income of 4,500,000 contributed positively to equity growth.
- Dividend payments of 9,500,000 reduced retained earnings.
- Other comprehensive income decreased equity by 11,000,000.
- Other factors increased equity by 14,200,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX4.50 Million | +1.23% |
| Dividends Paid | GBX9.50 Million | -2.59% |
| Other Comprehensive Income | GBX-11.00 Million | -3.0% |
| Other Changes | GBX14.20 Million | +3.88% |
| Total Change | GBX- | -0.49% |
Book Value vs Market Value Analysis
This analysis compares Dr. Martens PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 164.83x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 39880.65x to 164.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | GBX0.00 | GBX62.00 | x |
| 2015-03-31 | GBX0.00 | GBX62.00 | x |
| 2016-03-31 | GBX-0.01 | GBX62.00 | x |
| 2017-03-31 | GBX-0.02 | GBX62.00 | x |
| 2018-03-31 | GBX-0.06 | GBX62.00 | x |
| 2019-03-31 | GBX-0.02 | GBX62.00 | x |
| 2020-03-31 | GBX0.20 | GBX62.00 | x |
| 2021-03-31 | GBX0.15 | GBX62.00 | x |
| 2022-03-31 | GBX0.33 | GBX62.00 | x |
| 2023-03-31 | GBX0.40 | GBX62.00 | x |
| 2024-03-31 | GBX0.37 | GBX62.00 | x |
| 2025-03-31 | GBX0.38 | GBX62.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr. Martens PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.57%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 2.43x
- Recent ROE (1.23%) is above the historical average (-155.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -2122.02% | -19.52% | 0.48x | 226.23x | GBX-32.15 Million |
| 2015 | 25.00% | 0.08% | 0.65x | 454.00x | GBX120.00K |
| 2016 | 0.00% | -5.16% | 0.62x | 0.00x | GBX-10.90 Million |
| 2017 | 0.00% | -3.89% | 0.69x | 0.00x | GBX-9.50 Million |
| 2018 | 0.00% | -1.64% | 0.78x | 0.00x | GBX-2.76 Million |
| 2019 | 0.00% | 3.79% | 1.01x | 0.00x | GBX18.04 Million |
| 2020 | 106.10% | 11.13% | 1.02x | 9.31x | GBX67.75 Million |
| 2021 | 23.03% | 4.49% | 1.18x | 4.33x | GBX19.63 Million |
| 2022 | 55.21% | 19.95% | 1.06x | 2.62x | GBX148.38 Million |
| 2023 | 31.89% | 12.89% | 1.01x | 2.46x | GBX88.48 Million |
| 2024 | 18.79% | 7.89% | 0.92x | 2.59x | GBX32.38 Million |
| 2025 | 1.23% | 0.57% | 0.89x | 2.43x | GBX-32.14 Million |
Industry Comparison
This section compares Dr. Martens PLC's net assets metrics with peer companies in the Footwear & Accessories industry.
Industry Context
- Industry: Footwear & Accessories
- Average net assets among peers: $78,709,000
- Average return on equity (ROE) among peers: 23.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr. Martens PLC (DOCS) | GBX329.10 Million | -2122.02% | 1.63x | $7.29 Million |
| Mulberry Group PLC (MUL) | $78.71 Million | 23.75% | 0.42x | $981.70K |
About Dr. Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.